Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

Clinical trial NCT00004772 · COMPLETED

Trial details

NCT number

NCT00004772

Sponsor

National Center for Research Resources (NCRR)

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

1992-09-01

Enrollment

90

View on ClinicalTrials.gov